Venous Thromboembolism Treatment Market Size Report, Industry Share, Analysis, Growth, 2030

Venous Thromboembolism Treatment Industry Prospective:

The global venous thromboembolism treatment market size was evaluated at $7.1 billion in 2022 and is slated to hit $10.3 billion by the end of 2030 with a CAGR of nearly 6.2% between 2023 and 2030.

Request Free Sample

Venous Thromboembolism Treatment Market: Overview

Venous thromboembolism (VTE) is defined as a clot of blood beginning in a vein. It is the third leading vascular disease that affects about 300,000 and 600,000 Americans every year following heart attack and stroke. Operation, cancer, immobilization, and hospitalization are the most common factors that trigger venous thromboembolism. Deep vein thrombosis is observed in the legs when the blood flow slows down or changes are observed in the blood flow. In women, during pregnancy, the use of hormones for menopause symptoms, such as oral contraceptives or estrogen, can also play a vital role in causing venous thromboembolism.  

Key Insights

• As per the analysis shared by our research analyst, the global venous thromboembolism treatment market is projected to expand annually at the annual growth rate of around 6.2% over the forecast timespan (2023-2030)
• In terms of revenue, the global venous thromboembolism treatment market size was evaluated at nearly $7.1 billion in 2022 and is expected to reach $10.3 billion by 2030.
• The global venous thromboembolism treatment market is anticipated to grow rapidly over the forecast timeline owing to a surge in heart disorders and an increase in the occurrence of cancer.
• In terms of product, the retrievable inferior vena cava filters segment is slated to register the highest CAGR over the analysis period.
• Based on the end-user, the hospital segment is set to dominate the end-user segment over the forecast period.
• Based on the disease indication, the pulmonary embolism segment is anticipated to lead the disease indication segment over the forecast period.
• Region-wise, the Asia-Pacific venous thromboembolism treatment industry is projected to register the fastest CAGR during the assessment timeline.

Request Free Sample

Venous Thromboembolism Treatment Market: Growth Factors

A rise in chronic ailments will boost the global market expansion over the forecast period

Evidence-based recommendations are available to support healthcare providers in clinical decision-making to treat pulmonary embolism & deep vein thrombosis and this aspect can propel the global venous thromboembolism treatment market growth. Furthermore, escalating demand for cost-effective treatment is also expected to boost the growth of the market globally. Increasing rates of inferior vena cava filters will bolster the global market trends. A surge in heart disorders and an increase in the occurrence of cancer can prompt the demand for venous thromboembolism treatment. Growing awareness among the people about venous thromboembolism treatment will proliferate the size of the global market in the years ahead.

The launching of anticoagulant drugs by pharmaceutical firms is predicted to embellish the global market demand. An increase in the cases of venous thromboembolism can be attributed to an inactive lifestyle, huge alcohol consumption, and intake of a non-nutritive diet and this can pave the way for massive demand for venous thromboembolism treatment. New product launches have always influenced the growth of every sector and the medical sector is no exception to this. For instance, in the first half of 2021, Jansen Pharmaceuticals, Inc., a key pharmaceutical firm based in Belgium, declared that it received approval from the U.S.FDA for its newly launched product referred to as XARELTO® for treating pulmonary embolism and deep venous thrombosis.

Venous Thromboembolism Treatment Market: Restraints

The growing use of antibiotics that can cause adverse effects on patient health can impede the global industry expansion

Treatment of venous thromboembolism depends on antibiotics that can have side effects on the health of patients. This, in turn, can hamper the growth of the global venous thromboembolism treatment industry expansion.

Venous Thromboembolism Treatment Market: Opportunities

The emergence of a plethora of surgical treatments will create new growth horizons for the global market over 2023-2030

The evolution of a slew of mechanical and surgical therapies will open new growth avenues for the global venous thromboembolism treatment market in the upcoming years. A surge in the number of orthopedic surgical operations will help the global market explore new growth spaces in the coming years.

Venous Thromboembolism Treatment Market: Challenges

Complications arising after medical treatment and stent placement can prove to be a big challenge for the global industry expansion

Post-procedure complications related to stent placement and low awareness about venous thromboembolism treatment will pose a huge challenge to the global venous thromboembolism treatment industry expansion.

Venous Thromboembolism Treatment Market: Segmentation

The global venous thromboembolism treatment market is sectored into product, disease indication, end-user, and region.         

In terms of product, global venous thromboembolism treatment market is segregated into upper pneumatic compression sleeves, lower pneumatic compression sleeves, permanent inferior vena cava filters, retrievable inferior vena cava filters, embolectomy balloon catheters, percutaneous thrombectomy devices, catheter-directed thrombolysis (CDT) devices, non-segmented pneumatic compression pumps, segmented pneumatic compression pumps without gradient, and segmented pneumatic compression pumps with calibrated gradient segments.

Furthermore, the retrievable inferior vena cava filters segment, which gained nearly 52% of the global market revenue in 2022, is expected to record the fastest CAGR in the forecasting timeline. The growth of the segment in the forecasting years can be due to the benefits such as health improvement, effectiveness, percutaneous recovery, and protection from pulmonary embolism provided by retrievable inferior vena cava filters to patients.

Based on disease indication, the global venous thromboembolism treatment industry is segmented into deep venous thrombosis and pulmonary embolism segments. During the expected timeframe, the pulmonary embolism segment is projected to observe a massive surge. The segmental surge can be primarily attributed to increased pulmonary embolism prevalence. In addition, various programs are planned to encourage segmental growth to increase public understanding of pulmonary embolism.

Based on end-user, the venous thromboembolism treatment market is segmented into hospitals, ambulatory surgical centers, clinics, and others. The hospital segment is projected to grow exponentially over the analysis period. The segmental expansion can be attributed to an upsurge in the patient population base coupled with increasing vena cava surgical procedures performed by surgeons in hospitals.

Venous Thromboembolism Treatment Market: Report Scope

Venous Thromboembolism Treatment Market: Regional Insights

North America is anticipated to maintain its global market leadership position over the expected timeframe

North American venous thromboembolism treatment market is expected to dominate the global market earnings due to increased demand for advanced therapy along with well-established healthcare infrastructure. In addition, the increasing prevalence of venous thromboembolism promotes local development. The growing occurrence of the disease in the U.S. will contribute notably towards the growth of the market in North America. The presence of key players in the sub-continent is going to play a key role in leveraging the regional market expansion.

The venous thromboembolism treatment industry in the Asia-Pacific is expected to grow at a significant rate over forecasting years due to growing demand for cost-effective treatment combined with improving the region's healthcare infrastructure. Increasing spending on healthcare will further promote regional business growth.

 Venous Thromboembolism Treatment Market: Competitive Space

The global venous thromboembolism treatment market profiles key players such as:

• Stryker Corporation
• Argon Medical Devices
• Cardinal Health (Medtronic)
• Cook Medical
• Boston Scientific Corporation
• Koninklijke Philips N.V.
• Arjo
• DJO Global

The global venous thromboembolism treatment market is segmented as follows:

By Product

• Upper Pneumatic Compression Sleeves
• Lower Pneumatic Compression Sleeves
• Permanent Inferior Vena Cava Filters
• Retrievable Inferior Vena Cava Filters
• Embolectomy Balloon Catheters
• Percutaneous Thrombectomy Devices
• Catheter-Directed Thrombolysis (CDT) Devices
• Non-Segmented Pneumatic Compression Pumps
• Segmented Pneumatic Compression Pumps Without Gradient
• Segmented Pneumatic Compression Pumps With Calibrated Gradient

By Disease Indication

• Deep Venous Thrombosis
• Pulmonary Embolism

By End-User

• Hospitals
•  Ambulatory Surgical Centers
•  Clinics
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa